Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Ochsner Clinic
Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection | SpringerLink
Abstract Background Recurrent Clostridioides difficile infection, associated with dysbiosis of gut microbiota, has substantial disease burden in the USA. RBX2660 is a live biotherapeutic product consisting of a broad consortium of microbes prepared from human stool that is under investigation for the reduction of recurrent C. difficile infection.
Leveraging COVID-19-Inspired Changes to Advance Otolaryngology-Here to Stay
[Skip to Content Landing] Purchase access Buy this article and get unlimited access and a printable PDF ($30.00) - Sign in or create a free account Rent this article for read-only access ($8.99) Sign in to download free article PDFs Get free access to newly published articles Create a personal account or sign in to: Register for email alerts with links to free full-text articles Access PDFs of free articles Manage your interests Save searches and receive search alerts Get free access to...
Does Chronic Rhinosinusitis Lead to Psychiatric Disease?
The Original Investigation by Kim and colleagues1 in this issue of JAMA Otolaryngology–Head & Neck Surgery investigates the association between chronic rhinosinusitis (CRS) and common psychiatric disorders, a topic that has been often discussed but rarely subjected to large-scale, population-based study.2-4 The investigators used data from a national health service database during an 11-year period to determine the incidence and risk of depression and anxiety in a population with CRS.
Microaggression in Radiology
Artificial Intelligence May Cause a Significant Disruption to the Radiology Workforce
Comparison of the Prognostic Utility of the Cell Cycle Progression Score for Predicting Clinical Outcomes in African American and Non-African American Men with Localized Prostate Cancer
1. Introduction Localized prostate cancer has a highly variable natural history. This leads to significant clinical uncertainty regarding appropriate management for patients with newly diagnosed low-risk disease, with options ranging from radical intervention to surveillance with the potential for deferred treatment [1x[1]Mohler, J.L., Antonarakis, E.S., Armstrong, A.J. et al. Prostate Cancer V2.2017. National Comprehensive Cancer Network clinical practice guidelines in oncology.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Ochsner
Contact Ochsner, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack